BioSpace News Archive

EyePoint Pharmaceuticals, Inc., a pharmaceutical company committed to developing and commercializing therapeutics to help improve the lives of patients with serious eye disorders, announced that the Company expects to receive a nine month extension on DEXYCU®’s pass-through payment status, which otherwise would expire on March 31, 2022.

Ortho Regenerative today announced that it has provided and filed all requested CMC-related data and characterization information in a formal response to the U.S. Food and Drug Administration.

RedHill Biopharma Ltd., a specialty biopharmaceutical company, announced that OptumRx, part of the UnitedHealth Group - a leader in healthcare coverage, partnered with more than 1.3 million healthcare professionals and 6,500 hospitals, has added Talicia® [1] to its Commercial Formulary as an unrestricted brand for H. pylori treatment, effective July 1, 2021.

Collaboration to leverage IONTAS proprietary mammalian display technology and other world-class discovery technologies

EQRx today announced the formation of its mission advisory board.

Mindset Pharma Inc. today announced the appointment of Dr. Ishrat Husain to its Scientific Advisory Board.

Beyond Air, Inc. today announced that it will report financial results for its first fiscal quarter ended June 30, 2021 on Tuesday, August 10, 2021.

KA Imaging has been awarded a group purchasing agreement for a Technology Breakthrough with Premier Inc.

Enzolytics, Inc. announces the signing of a Letter of Intent (LOI) with Creative Biolabs to complete the joint production and commercialization of HTLV-1 monoclonal antibodies by combining the technologies of the companies.

Creative Medical Technology Holdings Inc. announced today the launching of its second Regenerative Immunology product, MyeloCelz™.